Beyond the PGx Report: Building Services That Support Real-World Prescribing

Scaling to Enhance Clinical Impact and Commercial Sustainability

Pharmacogenomics (PGx) is a foundational component of precision medicine, yet many laboratories and health systems continue to face challenges translating PGx results into routine clinical workflows. As PGx expands beyond niche use cases, there is growing demand for scalable approaches that integrate testing, reporting, and clinical decision support (CDS) across diverse care settings to enhance both clinical impact and commercial sustainability.

This webinar will illustrate how PGx can be operationalized in real‑world clinical practices through a series of case vignettes spanning oncology, cardiology, and long‑term care.

Through examination of these real-life examples, the speaker will demonstrate how laboratories and health systems can incorporate PGx into their existing workflows, align PGx with guideline‑driven care, and leverage CDS to support precision prescribing throughout a patient’s clinical journey.

Learning Objectives

This webinar will help you:

• Describe how pharmacogenomic testing can be integrated into routine clinical workflows across oncology, cardiology, and long‑term care settings
• Evaluate the role of PGx reporting and clinical decision support in guiding precision prescribing when multiple clinical factors—including drug‑gene and drug‑drug interactions—must be considered
• Identify implementation strategies that enable laboratories and health systems to scale PGx programs while supporting both clinical outcomes and commercial viability

Fisher Healthcare is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.™ Program. One P.A.C.E.™ credit-hour will be provided for this complimentary basic level program.